|

Dapagliflozin Clinical Trials

11 actively recruiting trials across 2 locations

Also known as: FORXIGA, Farxiga, Forxiga, farxiga

Other8 trials

Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)
Phase 4
CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL
Phase 3
Dapagliflozin in Depression
Phase 1/2
Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure
Phase 4
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
Phase 3
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
Phase 2/3
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Phase 3
Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients
Phase 3

St Louis, Missouri2 trials

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Washington University School of Medicine

Phase 1
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Washington University School of Medicine/St. Louis Children's Hospital

Phase 1

San Antonio, Texas1 trial

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

The University of Texas Health Science Center at San Antonio

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.